Dentlabas - Company finances
|
EUR
|
2021
From: 2021-10-13
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 51,059 | 54,785 | 64,734 | 60,345 |
| Profit before tax | -18 | 8,820 | 4,679 | 25,929 | 15,988 |
| Net profit | -18 | 8,328 | 4,234 | 25,023 | 15,527 |
| Equity | 132 | 8,460 | 12,694 | 29,717 | 13,128 |
| Liabilities | - | 1,750 | 948 | 2,396 | 1,458 |
| Non-current assets | 0 | 0 | 3,033 | 4,334 | 3,301 |
| Current assets | 150 | 10,210 | 10,609 | 27,779 | 11,285 |
| Total assets | 150 | 10,210 | 13,642 | 32,113 | 14,586 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 4,550 | 678 | 692 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +7.3% | +18.2% | -6.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.0% | 81.6% | 31.0% | 77.9% | 106.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -13.6% | 98.4% | 33.4% | 84.2% | 118.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 16.3% | 7.7% | 38.7% | 25.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 17.3% | 8.5% | 40.1% | 26.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dentlabas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-16 | 2025-10-31 | 102.25 |
| 2025-10-01 | 2025-10-15 | 174.70 |
| 2025-09-15 | 2025-09-30 | 102.25 |
| 2025-09-10 | 2025-09-14 | 174.70 |
| 2025-08-13 | 2025-08-31 | 174.70 |
| 2025-07-15 | 2025-07-31 | 174.70 |
| 2025-06-19 | 2025-06-30 | 174.70 |
| 2025-06-11 | 2025-06-18 | 421.85 |
| 2025-06-03 | 2025-06-10 | 72.45 |
| 2025-05-13 | 2025-05-31 | 392.19 |
| 2025-05-04 | 2025-05-12 | 217.49 |
| 2025-04-15 | 2025-04-30 | 145.04 |
| 2023-07-19 | 2023-07-31 | 1333.08 |
| 2022-08-02 | 2022-08-31 | 50.95 |
Dentlabas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dentlabas, MB (code 305916594) is a small partnership operating in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of EUR 60.3K and net profit of EUR 15.5K, corresponding to a profit margin of 25.7%. Revenue declined by 6.8% year on year in 2025 after reaching EUR 64.7K in 2024, but it remained above the 2023 level of EUR 54.8K, indicating moderate two-year growth of 10.2%. Profitability was much stronger in 2024, when net profit reached EUR 25.0K, compared with EUR 4.2K in 2023 and EUR 15.5K in 2025. At the end of 2025, total assets stood at EUR 14.6K, equity at EUR 13.1K and liabilities at EUR 1.5K. The balance sheet remained lightly leveraged, with an equity ratio of 90.0% and debt-to-equity of 0.11. Asset turnover was 4.14x, while return metrics were very high relative to the small equity and asset base.